Clinical trial AMC303-01
A safety, tolerability and pharmacokinetic dose escalation expansion, Phase I/Ib study of AMC303 as monotherapy in patients with advanced or metastatic, malignant solid tumour of epithelial origin
Cancers | |
---|---|
Organ | Multiple |
Trial status | Trial closed |
Investigator | |
Trial type |
Interventional with experimental drug
|
Phase | Trial phase 1/1b |
Academic trial | Non |
Sponsor | Amcure GmbH |
EudraCT Identifier | 2016-001358-16 |
ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT03009214 |
Inclusion criteria | any line RECIST 1.1 |
Last update |